L3VLUP
ProSign in

RXRX in the 13F filings

Recursion Pharmaceuticals Inc · CUSIP 75629V104

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Dec 2025
the date the book describes
Filed
27 Oct 2026
latest of these filings; the earliest 23 Jan 2026
Managers listing it
25
at least, of 95 tracked, among listed positions
Comparable managers
92
filed both Q3 2025 and Q4 2025; 2 listed it in both
Shares listed
83,389,417
combined, among listed positions
Reported value
$341m
combined, at the quarter end

Among the 92 comparable managers: 18 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +9,320,177.

Managers listing RXRX in Q4 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

25 of 25 holders

ActionFiling
ARK Investment Management LLC37,316,856$153m1.01%Added+3,771,35711 Feb 2026 (the filing on sec.gov)
Baillie Gifford & Co23,774,972$97m0.08%Trimmed-203,72323 Jan 2026 (the filing on sec.gov)
Susquehanna International Group LLP4,396,104$18munder 0.1%Trimmed-993,07217 Feb 2026 (the filing on sec.gov)
Citadel Advisors LLC4,229,999$17munder 0.1%Added+2,881,31517 Feb 2026 (the filing on sec.gov)
Fidelity (FMR LLC)3,241,892$13munder 0.1%Added+13,03517 Feb 2026 (the filing on sec.gov)
Two Sigma Investments LP3,075,123$13munder 0.1%Added+624,31817 Feb 2026 (the filing on sec.gov)
Millennium Management LLC1,495,839$6.1munder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Squarepoint Ops LLC887,004$3.6munder 0.1%Newnew13 Feb 2026 (the filing on sec.gov)
Balyasny Asset Management LLC668,174$2.7munder 0.1%Added+105,72617 Feb 2026 (the filing on sec.gov)
Point72 Asset Management LP654,211$2.7munder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Invesco Ltd526,144$2.2munder 0.1%Added+107,97919 Feb 2026 (the filing on sec.gov)
Hudson Bay Capital Management LP425,000$1.7munder 0.1%Added+200,00013 Feb 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc415,363$1.7munder 0.1%Added+96,47917 Feb 2026 (the filing on sec.gov)
Verition Fund Management LLC412,747$1.7munder 0.1%Added+358,16913 Feb 2026 (the filing on sec.gov)
ExodusPoint Capital Management LP391,801$1.6munder 0.1%Added+186,56417 Feb 2026 (the filing on sec.gov)
AllianceBernstein LP361,374$1.5munder 0.1%Trimmed-50817 Feb 2026 (the filing on sec.gov)
Two Sigma Advisers LP313,945$1.3munder 0.1%Trimmed-501,50017 Feb 2026 (the filing on sec.gov)
Marshall Wace LLP226,609$927kunder 0.1%Added+148,35013 Feb 2026 (the filing on sec.gov)
Wellington Management Group LLP152,616$624kunder 0.1%Trimmed-66117 Feb 2026 (the filing on sec.gov)
Janus Henderson Group Ltd138,209$565kunder 0.1%Held017 Feb 2026 (the filing on sec.gov)
Jane Street Group LLC125,075$512kunder 0.1%Trimmed-596,47912 Feb 2026 (the filing on sec.gov)
D. E. Shaw & Co.89,544$366kunder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Man Group PLC27,960$114kunder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Neuberger Berman Group LLC24,010$98kunder 0.1%Added+6,93727 Oct 2026 (the filing on sec.gov)
Quantbot Technologies LP18,846$77kunder 0.1%Added+6,40210 Feb 2026 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2025 to Q4 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (5)

Exited (2)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
3 in Q3 2024 to 2 in Q2 2026

Tracked managers listing it, at least.

012320222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
RXRX by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20212$763mn.a.n.a.
Q3 20212$567mn.a.n.a.
Q4 20212$417mn.a.n.a.
Q1 20222$178mn.a.n.a.
Q2 20222$193mn.a.n.a.
Q3 20222$266mn.a.n.a.
Q4 20222$215mn.a.n.a.
Q1 20232$192mn.a.n.a.
Q2 20232$223mn.a.n.a.
Q3 20232$240mn.a.n.a.
Q4 20232$442m11
Q1 20242$485m11
Q2 20243$415m30
Q3 20243$387m21
Q4 20242$387m02
Q1 20253$315m21
Q2 20252$289m02
Q3 20252$281m11
Q4 20252$250m188
Q1 20262$196m1712
Q2 20262$238m1314

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

RXRX and GILD →RXRX and AMGN →RXRX and ARGX →Choose a stock to compare with RXRX →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own RXRX, latest filings →Back to the 13F Explorer →